36176016|t|Resolvin D1: A key endogenous inhibitor of neuroinflammation.
36176016|a|After the initiation of inflammation, a series of processes start to resolve the inflammation. A group of endogenous lipid mediators, namely specialized pro-resolving lipid mediators is at the top list of inflammation resolution. Resolvin D1 (RvD1), is one of the lipid mediators with significant anti-inflammatory properties. It is produced from docosahexaenoic acid (omega-3 polyunsaturated fatty acid) in the body. In this article, we aimed to review the most recent findings concerning the pharmacological effects of RvD1 in the central nervous system with a focus on major neurological diseases and dysfunctions. A literature review of the past studies demonstrated that RvD1 plasma level changes during mania, depression, and Parkinson's disease. Furthermore, RVD1 and its epimer, aspirin-triggered RvD1 (AT-RvD1), have significant therapeutic effects on experimental models of ischemic and traumatic brain injuries, memory dysfunction, pain, depression, amyotrophic lateral sclerosis, and Alzheimer's and Parkinson's diseases. Interestingly, the beneficial effects of RvD1 and AT-RvD1 were mostly induced at nanomolar and micromolar concentrations implying the significant potency of these lipid mediators in treating diseases with inflammation.
36176016	0	11	Resolvin D1	Chemical	MESH:C518399
36176016	43	60	neuroinflammation	Disease	MESH:D000090862
36176016	86	98	inflammation	Disease	MESH:D007249
36176016	143	155	inflammation	Disease	MESH:D007249
36176016	179	184	lipid	Chemical	MESH:D008055
36176016	229	234	lipid	Chemical	MESH:D008055
36176016	267	279	inflammation	Disease	MESH:D007249
36176016	292	303	Resolvin D1	Chemical	MESH:C518399
36176016	305	309	RvD1	Chemical	MESH:C518399
36176016	326	331	lipid	Chemical	MESH:D008055
36176016	364	376	inflammatory	Disease	MESH:D007249
36176016	409	429	docosahexaenoic acid	Chemical	MESH:D004281
36176016	431	465	omega-3 polyunsaturated fatty acid	Chemical	-
36176016	583	587	RvD1	Chemical	MESH:C518399
36176016	640	678	neurological diseases and dysfunctions	Disease	MESH:D009461
36176016	738	742	RvD1	Chemical	MESH:C518399
36176016	771	776	mania	Disease	MESH:D001714
36176016	778	788	depression	Disease	MESH:D003866
36176016	794	813	Parkinson's disease	Disease	MESH:D010300
36176016	828	832	RVD1	Chemical	MESH:C518399
36176016	849	856	aspirin	Chemical	MESH:D001241
36176016	867	871	RvD1	Chemical	MESH:C518399
36176016	873	880	AT-RvD1	Chemical	-
36176016	946	954	ischemic	Disease	MESH:D002545
36176016	959	983	traumatic brain injuries	Disease	MESH:D000070642
36176016	985	1003	memory dysfunction	Disease	MESH:D008569
36176016	1005	1009	pain	Disease	MESH:D010146
36176016	1011	1021	depression	Disease	MESH:D003866
36176016	1023	1052	amyotrophic lateral sclerosis	Disease	MESH:D000690
36176016	1058	1094	Alzheimer's and Parkinson's diseases	Disease	MESH:D010300
36176016	1137	1141	RvD1	Chemical	MESH:C518399
36176016	1146	1153	AT-RvD1	Chemical	-
36176016	1259	1264	lipid	Chemical	MESH:D008055
36176016	1301	1313	inflammation	Disease	MESH:D007249
36176016	Positive_Correlation	MESH:C518399	MESH:D001241
36176016	Negative_Correlation	MESH:D008055	MESH:D007249
36176016	Association	MESH:D001241	MESH:D010146
36176016	Association	MESH:D001241	MESH:D002545
36176016	Association	MESH:D001241	MESH:D000690
36176016	Negative_Correlation	MESH:C518399	MESH:D002545
36176016	Negative_Correlation	MESH:C518399	MESH:D007249
36176016	Negative_Correlation	MESH:C518399	MESH:D000690
36176016	Negative_Correlation	MESH:C518399	MESH:D000070642
36176016	Association	MESH:C518399	MESH:D009461
36176016	Negative_Correlation	MESH:C518399	MESH:D010146
36176016	Association	MESH:D001241	MESH:D008569
36176016	Negative_Correlation	MESH:C518399	MESH:D008569
36176016	Association	MESH:D001241	MESH:D000070642
36176016	Negative_Correlation	MESH:C518399	MESH:D010300
36176016	Negative_Correlation	MESH:C518399	MESH:D000090862
36176016	Association	MESH:C518399	MESH:D001714
36176016	Association	MESH:C518399	MESH:D003866

